{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":135,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":135,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"ded5295a5df6","filters":{"venue":"Journal of Comparative Effectiveness Research"}},"results":[{"id":"W4206611799","doi":"10.2217/cer-2021-0258","title":"Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Prehabilitation; Medicine; Mobilization; Perioperative; Intensive care medicine; Physical medicine and rehabilitation; Adverse effect; Physical therapy; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1843360096454225,"gpt":0.4388529752428572,"spread":0.2545169655974346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007485966,0.0001910574,0.0008524687,0.001251168,0.0001519027,0.00004523622,0.0001367385,0.0000446339,0.0001620569],"category_scores_gemma":[0.00100314,0.0001707094,0.0001488242,0.001441646,0.000143256,0.000753421,0.0002281417,0.00133741,0.000006464194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001129307,"about_ca_system_score_gemma":0.0007267113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000875083,"about_ca_topic_score_gemma":0.000006231423,"domain_scores_codex":[0.9929295,0.004071552,0.0007426971,0.0003655785,0.00145775,0.0004329672],"domain_scores_gemma":[0.9922876,0.00588849,0.0003263304,0.0002330072,0.001082988,0.0001816357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06641027,0.002972249,0.6609496,0.00141189,0.0002867617,0.0007377926,0.003623695,0.003660678,0.1130223,0.00002954382,0.0003855899,0.1465096],"study_design_scores_gemma":[0.001575237,0.003018262,0.9364035,0.004019791,0.00002464784,0.0001011288,0.0005374085,0.0001262878,0.05165251,0.0007973281,0.001521878,0.0002220675],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794026,0.01648743,0.002223363,0.00007123215,0.0008263619,0.0009102366,0.000006373104,0.000007250595,0.00006515141],"genre_scores_gemma":[0.9932548,0.006029916,0.00007889513,0.00001906697,0.0001097049,0.0004559066,0.000003874644,0.00002009383,0.00002778295],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2754538,"threshold_uncertainty_score":0.6961329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1877489180","doi":"10.2217/cer.15.38","title":"Systematic overview of cost–effectiveness thresholds in ten countries across four continents","year":2015,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":149,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Comparative effectiveness research; MEDLINE; Pathology; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.7926023616127016,"gpt":0.6204472118303856,"spread":0.1721551497823159,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1353201,0.0002810921,0.003781425,0.00102215,0.000153069,0.0001398192,0.0007381265,0.0001695184,0.00002980064],"category_scores_gemma":[0.01017812,0.000272573,0.0002649,0.0009652708,0.0003724419,0.001021001,0.0001675617,0.0007241546,0.0002541926],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002055256,"about_ca_system_score_gemma":0.0007627418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005533114,"about_ca_topic_score_gemma":0.0001610828,"domain_scores_codex":[0.9816668,0.0111043,0.005330349,0.0004262587,0.0007738183,0.0006984766],"domain_scores_gemma":[0.9776362,0.01563507,0.003698597,0.0004836209,0.002217025,0.0003295159],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002265077,0.0009388691,0.8672377,0.05586817,0.0009078248,0.00005406501,0.01346193,0.006722766,0.0000938594,0.05056754,0.001845249,0.0000369549],"study_design_scores_gemma":[0.009901769,0.001665213,0.9113455,0.02907513,0.00002701583,0.0001099432,0.007613077,0.003039871,0.0008947223,0.03409014,0.001665539,0.0005721202],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9749052,0.01749899,0.002518725,0.0007389323,0.0006016724,0.003007142,0.00009582139,0.000008388166,0.0006251674],"genre_scores_gemma":[0.9990392,0.00023271,0.0001295858,0.00007948438,0.0001537049,0.0002844407,0.000003572351,0.00002923932,0.00004807434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1251419,"threshold_uncertainty_score":0.9999726,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003321779","doi":"10.2217/cer.14.76","title":"EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review","year":2015,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; MEDLINE; Quality of life (healthcare); Population; Family medicine; Cancer; Gerontology; Clinical psychology; Internal medicine; Environmental health; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.225691493297936,"gpt":0.5681167581685256,"spread":0.3424252648705896,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008916451,0.0003127771,0.004570063,0.0004304742,0.00005248637,0.00002619796,0.0003013314,0.0001511736,0.00001627015],"category_scores_gemma":[0.0002689132,0.0001521695,0.0003902035,0.001152899,0.0003071565,0.000129022,0.00009219569,0.001405473,1.690879e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005531751,"about_ca_system_score_gemma":0.003099075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002283023,"about_ca_topic_score_gemma":0.0002088848,"domain_scores_codex":[0.9925616,0.004088168,0.001211082,0.000261361,0.001612268,0.0002655447],"domain_scores_gemma":[0.9873976,0.004044993,0.001370679,0.0003436609,0.006635046,0.0002080074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"observational","study_design_scores_codex":[0.006398628,0.0009825226,0.08742684,0.513334,0.00247929,0.00001194325,0.001007246,0.000009740764,0.000002037137,0.0001939802,0.0007570501,0.3873967],"study_design_scores_gemma":[0.004784128,0.003076083,0.4545232,0.447769,0.0009775525,0.00003464502,0.0001982957,0.000006063362,0.00000297941,0.00003052539,0.0883671,0.0002304523],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007386726,0.9875759,0.00007845432,0.0001052538,0.0001235181,0.004141562,0.0005193704,0.000001393695,0.00006776591],"genre_scores_gemma":[0.05513507,0.9443138,0.00002169231,0.0000127635,0.0001143887,0.0003324946,0.00003429065,0.00002336163,0.00001211148],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3871663,"threshold_uncertainty_score":0.6205293,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3129382481","doi":"10.2217/cer-2020-0267","title":"Efficacy classification of modern therapies in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ocrelizumab; Cladribine; Ofatumumab; Multiple sclerosis; Relapsing remitting; Internal medicine; Placebo; MEDLINE; Oncology; Intensive care medicine; Alternative medicine; Rituximab; Pathology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.436733189315095,"gpt":0.4796674318923596,"spread":0.04293424257726453,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004387594,0.000164714,0.001022732,0.0008284219,0.0001299146,0.00003619186,0.0002312781,0.00009107425,0.00004960753],"category_scores_gemma":[0.003823624,0.0001271459,0.0002326746,0.001425683,0.0005477614,0.0002162112,0.0001461695,0.001002231,0.000009387128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004107603,"about_ca_system_score_gemma":0.0008398349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002740424,"about_ca_topic_score_gemma":0.00007664615,"domain_scores_codex":[0.9937113,0.003265376,0.0006894664,0.0002737487,0.001648162,0.0004119761],"domain_scores_gemma":[0.9861233,0.008677774,0.0002474658,0.000330922,0.004453756,0.0001667497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004542001,0.001707468,0.1872665,0.000355841,0.0003794309,0.00004967875,0.003062843,0.0003999931,0.7868711,0.0001439993,0.0001135676,0.01510751],"study_design_scores_gemma":[0.005327792,0.0006949479,0.7782831,0.001464234,0.00001440464,0.00001753817,0.001288413,0.001910062,0.2105471,0.0002751364,0.0001056018,0.0000716525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921694,0.004694711,0.001176864,0.0004295793,0.00006856816,0.0006937122,0.000006142677,0.000005790306,0.0007552688],"genre_scores_gemma":[0.9977134,0.001422198,0.000649229,0.000004966621,0.0001025964,0.00004922221,0.000003883704,0.00001743124,0.00003707418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5910166,"threshold_uncertainty_score":0.5184858,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3094115567","doi":"10.2217/cer-2020-0122","title":"Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Ofatumumab; Medicine; Natalizumab; Ocrelizumab; Alemtuzumab; Multiple sclerosis; Internal medicine; Meta-analysis; Oncology; Disease; Immunology; Rituximab","retraction":null,"screen_n_in":null,"score":{"opus":0.6942617178013222,"gpt":0.5352789439256699,"spread":0.1589827738756523,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004865789,0.0002799149,0.003282284,0.000571046,0.0003900959,0.00008172278,0.0002712957,0.00007606244,0.00005530284],"category_scores_gemma":[0.002111941,0.0001903941,0.001319512,0.001624027,0.000656191,0.0002028061,0.0001910222,0.0008165987,0.000001917027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001243773,"about_ca_system_score_gemma":0.0002290365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003148205,"about_ca_topic_score_gemma":0.00002022055,"domain_scores_codex":[0.9939282,0.002649344,0.0008976174,0.0004017894,0.001573634,0.0005494312],"domain_scores_gemma":[0.9867545,0.009453798,0.0005372859,0.0002688809,0.002477413,0.000508154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03453869,0.001225015,0.5973555,0.002235421,0.2632749,0.00001721664,0.0140116,0.01875313,0.06520031,0.0005289303,0.001276978,0.001582318],"study_design_scores_gemma":[0.008956924,0.004742072,0.825264,0.000768016,0.04614096,0.000004270996,0.004499537,0.0897702,0.01757225,0.0005005273,0.001410808,0.0003703799],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.901117,0.05911753,0.03537576,0.00162724,0.00005619815,0.002473003,0.00007158427,0.00001791069,0.0001437841],"genre_scores_gemma":[0.9957246,0.0002794415,0.003504519,0.0000495675,0.0002342286,0.0001631871,0.000003324015,0.00003063362,0.00001047059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2279086,"threshold_uncertainty_score":0.7764046,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3081136664","doi":"10.2217/cer-2020-0095","title":"Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy","year":2020,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of Calgary; Alberta Children's Hospital; Western University","funders":"National Institutes of Health; Ministero della Salute; Cytokinetics; Parent Project Muscular Dystrophy; Fondazione Telethon; PTC Therapeutics; Muscular Dystrophy Association; Sarepta Therapeutics; Ionis Pharmaceuticals; FibroGen; AveXis; Biogen; Bristol-Myers Squibb","keywords":"Medicine; Duchenne muscular dystrophy; Placebo; Internal medicine; Randomized controlled trial; Ambulatory; Nonsense mutation; Meta-analysis; Subgroup analysis; Physical therapy; Mutation; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.5116218416020909,"gpt":0.5738630164585028,"spread":0.0622411748564119,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03821991,0.0004983286,0.0231848,0.0009031905,0.00006616145,0.00003313001,0.0004858354,0.0003917408,0.00004977677],"category_scores_gemma":[0.01553454,0.0002734689,0.008219945,0.0006903381,0.000554106,0.00001357375,0.0001296353,0.0009515032,0.000005852927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005955844,"about_ca_system_score_gemma":0.001148508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002901332,"about_ca_topic_score_gemma":0.00000590274,"domain_scores_codex":[0.9155067,0.07969715,0.003348108,0.0004372867,0.0007088939,0.0003019111],"domain_scores_gemma":[0.9764146,0.01838131,0.003255556,0.0003401307,0.001479492,0.0001289752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6861932,0.001133114,0.000003510839,0.01203072,0.2324667,0.0002686263,0.0002788906,0.002548504,0.04033764,0.0002614521,0.0003698696,0.02410778],"study_design_scores_gemma":[0.6942933,0.008421006,0.0001090893,0.009831356,0.1378324,0.0002269003,0.0003787487,0.0003390136,0.02543166,0.003404329,0.1180917,0.001640552],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007290143,0.9866681,0.002120245,0.00002742988,0.0001048656,0.00364299,0.00003680525,0.000001646861,0.0001078183],"genre_scores_gemma":[0.1459645,0.853006,0.0001522622,0.000005299448,0.0002063685,0.0005417805,0.00008504561,0.00002676441,0.00001200747],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1386743,"threshold_uncertainty_score":0.9999717,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379093489","doi":"10.57264/cer-2023-0016","title":"Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis","year":2023,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ofatumumab; Alemtuzumab; Ocrelizumab; Natalizumab; Internal medicine; Placebo; Multiple sclerosis; Lipoarabinomannan; Oncology; Rituximab; Disease; Tuberculosis; Immunology; Alternative medicine; Pathology; Lymphoma","retraction":null,"screen_n_in":null,"score":{"opus":0.7093580791148476,"gpt":0.5626411172863962,"spread":0.1467169618284514,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0250095,0.0008701694,0.03329588,0.002355737,0.0004680311,0.0001175823,0.0007227767,0.0002746206,0.00003097477],"category_scores_gemma":[0.006839192,0.0005017773,0.007016021,0.005716523,0.0009739356,0.0002083235,0.0004158065,0.001966875,0.00001447056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004828802,"about_ca_system_score_gemma":0.0008378057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002177884,"about_ca_topic_score_gemma":0.00002500507,"domain_scores_codex":[0.9769212,0.01558813,0.003422416,0.0007456013,0.0024278,0.0008948697],"domain_scores_gemma":[0.9192491,0.07076028,0.002916728,0.0008341545,0.005866649,0.000373066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0004537702,0.0002822363,0.0000134379,0.6203665,0.3769443,0.000009801751,0.0005751818,0.00006913974,0.00001254679,0.00003525796,0.0005302657,0.0007075149],"study_design_scores_gemma":[0.001645555,0.001499896,0.0005581412,0.4757981,0.5170714,0.00003251599,0.0003797503,0.0001795053,0.000019924,0.00004514884,0.00243853,0.0003314839],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008915905,0.9815004,0.0008477793,0.000073166,0.00007291204,0.01721407,0.0001438734,0.00002046164,0.00003819569],"genre_scores_gemma":[0.005109358,0.9907178,0.0008348675,0.000009408754,0.0001793904,0.002923776,0.00003392135,0.00008293991,0.000108558],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1445684,"threshold_uncertainty_score":0.9997434,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3009343637","doi":"10.2217/cer-2019-0187","title":"Clinical therapeutic efficacy of mesenchymal stem cells derived from adipose or bone marrow for knee osteoarthritis: a meta-analysis of randomized controlled trials","year":2020,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; WOMAC; Randomized controlled trial; Meta-analysis; Cochrane Library; Mesenchymal stem cell; Clinical trial; Internal medicine; Bone marrow; Visual analogue scale; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.4233379971369119,"gpt":0.5279693907700566,"spread":0.1046313936331447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.05190999,0.0009656383,0.09443226,0.002344555,0.0001171394,0.00007580072,0.0005107831,0.0006371003,0.0004919363],"category_scores_gemma":[0.006803503,0.0004835483,0.04232228,0.001895987,0.0007615961,0.0001420379,0.0001311873,0.001542816,0.00001042693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000217474,"about_ca_system_score_gemma":0.00279678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001196125,"about_ca_topic_score_gemma":0.00001387561,"domain_scores_codex":[0.9257616,0.0614666,0.009252443,0.0007443256,0.002222779,0.0005522156],"domain_scores_gemma":[0.8055584,0.1825712,0.007431492,0.0005655881,0.003426954,0.0004463639],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.3898795,0.001026997,0.000002163475,0.002533191,0.4136753,0.0001894095,0.0002033256,0.000008182233,0.0009434958,0.00005929164,0.00001009554,0.191469],"study_design_scores_gemma":[0.3557545,0.02065865,0.000006673891,0.005606493,0.6104167,0.0000300318,0.0001454433,0.00005884789,0.002523266,0.00008459459,0.004463845,0.0002510349],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007410091,0.9649341,0.001391685,0.00003683142,0.0003937725,0.02513065,0.0006482142,0.00001105201,0.00004363414],"genre_scores_gemma":[0.09472658,0.8995751,0.001306777,0.00001255033,0.0005904128,0.003281735,0.0001354854,0.000116986,0.0002544395],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1967413,"threshold_uncertainty_score":0.9997616,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2895775669","doi":"10.2217/cer-2018-0065","title":"Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasis","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Covariate; Placebo; Meta-analysis; Psychological intervention; Clinical trial; Internal medicine; Physical therapy; Statistics; Alternative medicine; Psychiatry; Dermatology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.9347608835346701,"gpt":0.7117826814298529,"spread":0.2229782021048172,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3505504,0.0002790283,0.009835185,0.001621146,0.000328157,0.0005333509,0.001044588,0.00005733549,0.0002282039],"category_scores_gemma":[0.01714783,0.0001392153,0.002395849,0.00581945,0.0003207596,0.000460483,0.0002570476,0.0004001834,0.000003454374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006967889,"about_ca_system_score_gemma":0.0001439181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001480238,"about_ca_topic_score_gemma":0.002054377,"domain_scores_codex":[0.9140599,0.06852771,0.01029411,0.0008517074,0.005860354,0.000406161],"domain_scores_gemma":[0.9383516,0.03903906,0.008154143,0.001412961,0.0128932,0.0001490148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003409932,0.001182693,0.9390821,0.0001002279,0.04533073,0.0001279826,0.004895138,0.008307068,0.0001109939,0.00001983247,0.0000584624,0.0004437884],"study_design_scores_gemma":[0.0017489,0.003589455,0.9251434,0.00004716944,0.02723974,0.0001028591,0.03038262,0.01047647,0.0004209122,0.0006804928,0.00002119492,0.0001467623],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845545,0.001909895,0.01097531,0.000009446126,0.00007512293,0.002393787,0.000006827474,5.581332e-7,0.00007452013],"genre_scores_gemma":[0.9983498,0.00000223654,0.00140737,0.000002208887,0.00009958848,0.0001082052,2.032372e-7,0.000008195147,0.00002217364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3334026,"threshold_uncertainty_score":0.9911311,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090075299","doi":"10.2217/cer.13.91","title":"The vexing problem of defining the meaning, role and measurement of values in treatment decision-making","year":2014,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Meaning (existential); Value (mathematics); Medicine; Process (computing); Reductionism; Management science; Epistemology; Psychology; Computer science; Psychotherapist; Economics","retraction":null,"screen_n_in":null,"score":{"opus":0.5259805117371518,"gpt":0.602337979086101,"spread":0.07635746734894922,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.02256684,0.0003145179,0.002464009,0.000665971,0.001274302,0.00002921609,0.001072066,0.0002159555,0.000005809618],"category_scores_gemma":[0.003096934,0.0001537594,0.0003087405,0.000859371,0.0004590176,0.0001162327,0.00051734,0.002459026,0.00000613059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0018368,"about_ca_system_score_gemma":0.002881151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001964457,"about_ca_topic_score_gemma":0.0002695463,"domain_scores_codex":[0.9559055,0.03888326,0.002573035,0.0002657315,0.001840103,0.0005323778],"domain_scores_gemma":[0.9156359,0.07684189,0.003111833,0.0007190258,0.003594641,0.00009670507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0007838108,0.0002402394,0.006536909,0.02108484,0.0005969455,0.000003495962,0.02483462,0.0002328085,0.00001429032,0.00600456,0.00004588728,0.9396216],"study_design_scores_gemma":[0.002708575,0.003701273,0.01040208,0.6189552,0.0004700355,0.00003805771,0.03370538,0.0007461057,0.00006902812,0.02323811,0.3054942,0.0004720238],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002506964,0.992381,0.0001598673,0.00005099908,0.0001719699,0.003575355,0.000008894257,0.000003727489,0.001141207],"genre_scores_gemma":[0.3146889,0.6840832,0.0005739877,0.000001701965,0.00006630346,0.0005509409,0.000001267899,0.00002834372,0.000005360666],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9391496,"threshold_uncertainty_score":0.9998423,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2028846339","doi":"10.2217/cer.12.63","title":"The utilization of telephone follow-up in the advanced cancer population: a review of the literature","year":2012,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; CINAHL; MEDLINE; Population; Cochrane Library; Cancer; Clinical trial; Palliative care; Randomized controlled trial; Patient satisfaction; Family medicine; Physical therapy; Surgery; Psychological intervention; Internal medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.2474143260578469,"gpt":0.5369253003219292,"spread":0.2895109742640823,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008291189,0.0002633008,0.002185979,0.0002820937,0.0001601945,0.00002851875,0.000685994,0.0001586633,0.00002965167],"category_scores_gemma":[0.0005886634,0.0001029678,0.0008163629,0.003198297,0.0002514846,0.0001418546,0.00009744091,0.001806365,0.000001083458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004303646,"about_ca_system_score_gemma":0.000966708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001039535,"about_ca_topic_score_gemma":0.0003467932,"domain_scores_codex":[0.9884152,0.008319799,0.001093055,0.0001720352,0.001708861,0.0002910652],"domain_scores_gemma":[0.9915456,0.004099402,0.001246926,0.0005621098,0.002479714,0.00006623519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001190943,0.000251057,0.001762981,0.2052065,0.0005863698,0.0000106832,0.00411351,0.000008780537,0.00002713724,0.0004717316,0.0005714738,0.7857988],"study_design_scores_gemma":[0.0008294377,0.0003712336,0.01726313,0.4550399,0.0006513643,0.00009598175,0.0004605041,0.000002016777,0.0001057878,0.0001002553,0.5249667,0.0001136889],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002416519,0.9937068,0.00001542196,0.0001948228,0.000732917,0.002652045,0.00002801617,0.000001433841,0.0002520761],"genre_scores_gemma":[0.1004909,0.8988461,0.000003092285,0.00001877144,0.0002831764,0.0002392761,0.00001380541,0.00001866617,0.00008613571],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7856851,"threshold_uncertainty_score":0.7847856,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2065741177","doi":"10.2217/cer.14.41","title":"Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients","year":2014,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Quality of life (healthcare); Cancer; Medical physics; Oncology; Internal medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.7458504868248589,"gpt":0.6286639508228942,"spread":0.1171865360019647,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07990823,0.0002333222,0.00525798,0.0004748073,0.0001425167,0.00003471242,0.0004422021,0.0001310946,0.000009082983],"category_scores_gemma":[0.006776619,0.0001552034,0.0002825386,0.0003255768,0.0005773999,0.0001588374,0.0001846398,0.0006164343,8.502459e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005736941,"about_ca_system_score_gemma":0.001722618,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000248882,"about_ca_topic_score_gemma":0.00008841806,"domain_scores_codex":[0.9832767,0.009254226,0.006536801,0.000295158,0.0003706865,0.0002664323],"domain_scores_gemma":[0.9676633,0.0198925,0.01096302,0.0002934204,0.001087319,0.0001004136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008186509,0.000707769,0.8100866,0.1427612,0.001266052,1.641127e-7,0.005469958,0.00005784505,0.000001902755,0.02520625,0.0002061442,0.0134175],"study_design_scores_gemma":[0.003789011,0.0003293422,0.9381313,0.0113287,0.00005416307,9.487499e-7,0.0002987195,0.0002905467,0.00001034262,0.002031552,0.04351099,0.0002244293],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.648856,0.3446209,0.0005491084,0.0002598878,0.0002917415,0.004701507,0.0006510434,0.000001047866,0.00006877508],"genre_scores_gemma":[0.6274621,0.37167,0.0002957661,0.00002795687,0.00008216631,0.0004101011,0.00001260643,0.00002257969,0.00001664984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1314324,"threshold_uncertainty_score":0.9474281,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4280554311","doi":"10.2217/cer-2022-0040","title":"Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus","year":2022,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"National Institute for Health and Care Research; AstraZeneca","keywords":"Medicine; Belimumab; Lupus erythematosus; Monoclonal; Immunology; Internal medicine; Dermatology; Monoclonal antibody; Antibody; B-cell activating factor","retraction":null,"screen_n_in":null,"score":{"opus":0.2192202844116624,"gpt":0.4864674594319094,"spread":0.267247175020247,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007602446,0.0009951423,0.01146686,0.004631897,0.0002567495,0.00007160196,0.001084491,0.0003916472,0.0001734523],"category_scores_gemma":[0.0008438955,0.0006469175,0.0012497,0.004182399,0.0006096663,0.0001939825,0.0003512572,0.003771675,0.00004450014],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.008673818,"about_ca_system_score_gemma":0.006239344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001366384,"about_ca_topic_score_gemma":0.0001040058,"domain_scores_codex":[0.9773105,0.01281988,0.003090893,0.0009107877,0.004692766,0.001175187],"domain_scores_gemma":[0.9721093,0.02204003,0.002412499,0.001114476,0.00182129,0.0005024734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.1925958,0.01696336,0.05082624,0.3737443,0.01669531,0.008105159,0.02778531,0.0007013751,0.00005033228,0.0001829137,0.000477728,0.3118722],"study_design_scores_gemma":[0.09748426,0.0809094,0.0009946158,0.5557957,0.002868901,0.1264174,0.01953748,0.0002763954,0.0003828646,0.00001707297,0.1139397,0.001376097],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2452039,0.7465456,0.00001327251,0.000005473415,0.0005126998,0.006510252,0.00003764852,0.00001786115,0.001153329],"genre_scores_gemma":[0.3506007,0.648181,0.00005407943,2.72502e-7,0.0001623031,0.0007314655,0.00004344324,0.0001259312,0.0001008261],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3104962,"threshold_uncertainty_score":0.9995982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2914902447","doi":"10.2217/cer-2018-0140","title":"Medicaid spending burden among beneficiaries with treatment-resistant depression","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Mental Health Treatment and Access","field":"Psychology","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"H2020 European Research Council; Janssen Scientific Affairs","keywords":"Medicaid; Major depressive disorder; Medicine; Depression (economics); Treatment-resistant depression; Psychiatry; Cohort; Incidence (geometry); Emergency medicine; Health care; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1192136296832226,"gpt":0.4902222418828279,"spread":0.3710086121996052,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001997798,0.0002439365,0.0007588227,0.0005249548,0.0003718914,0.00009548419,0.0003553662,0.0001062684,0.001292761],"category_scores_gemma":[0.00002303078,0.0001438253,0.0001162794,0.0005089158,0.0002216938,0.0003938098,0.00006621955,0.0005573341,0.0002226951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005745391,"about_ca_system_score_gemma":0.0001224962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005678709,"about_ca_topic_score_gemma":0.0001287784,"domain_scores_codex":[0.9955343,0.002072505,0.0004404206,0.0003327723,0.001045005,0.0005750199],"domain_scores_gemma":[0.9959431,0.002726144,0.0003609432,0.0002952225,0.0004197671,0.0002548514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02465809,0.001326301,0.9324387,0.0002197908,0.001194997,0.0007133334,0.007789936,0.0004456497,0.005789189,0.002703085,0.0001681105,0.02255281],"study_design_scores_gemma":[0.007317629,0.00850309,0.9594072,0.001224887,0.00006273059,0.0000816736,0.005458344,0.0001356383,0.01610015,0.0004000187,0.001096284,0.0002123918],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827029,0.002177077,0.0001154668,0.00005493824,0.0004472047,0.001217755,0.000006328788,0.0000121645,0.0132662],"genre_scores_gemma":[0.9987124,0.00003867372,0.00006372484,0.000002574359,0.0002619,0.00008604737,0.000006077969,0.00002341202,0.0008051948],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02696845,"threshold_uncertainty_score":0.9996202,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404388316","doi":"10.57264/cer-2024-0118","title":"Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"LEO Pharma; Otsuka Pharmaceutical; Novo Nordisk; CVS Health; Regeneron Pharmaceuticals; Bayer HealthCare; Sanofi; National Pharmaceutical Council; Centene Corporation; Mallinckrodt Pharmaceuticals; Commonwealth Fund; Alnylam Pharmaceuticals; Kaiser Permanente; GlaxoSmithKline; National Organization for Rare Disorders; Arnold Ventures; AstraZeneca; Patrick and Catherine Weldon Donaghue Medical Research Foundation","keywords":"Medicine; Payment; Finance; Business","retraction":null,"screen_n_in":null,"score":{"opus":0.1974956848485162,"gpt":0.4900226394215382,"spread":0.292526954573022,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004511805,0.00007766017,0.0002504265,0.0006448304,0.0001372348,0.00003560024,0.0001219705,0.0002380197,0.000001603394],"category_scores_gemma":[0.00007049033,0.00003433126,0.00006950122,0.0005216596,0.0002659595,0.0001050087,0.00001977054,0.001375623,1.119157e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001028494,"about_ca_system_score_gemma":0.0001794438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006826046,"about_ca_topic_score_gemma":0.00001854947,"domain_scores_codex":[0.9987769,0.0005892196,0.0001930666,0.00009445003,0.0001788177,0.0001676189],"domain_scores_gemma":[0.9960913,0.003384837,0.00006632268,0.00009418061,0.0003440045,0.0000193598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.03880387,0.0008185754,0.0007855516,0.007030953,0.003924967,0.0001169937,0.06037199,0.001355991,0.08114535,0.6194157,0.001220218,0.1850099],"study_design_scores_gemma":[0.008823717,0.01433576,0.1371135,0.004609129,0.0001929271,0.0007508407,0.260318,0.04493836,0.1299529,0.3793405,0.01933696,0.0002874512],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9297729,0.02047552,0.004408173,0.0435691,0.00007539575,0.001107366,0.000003932183,0.00000720538,0.000580442],"genre_scores_gemma":[0.9806367,0.01908119,0.00006260889,0.0000331523,0.00009565263,0.00006762972,0.000001581107,0.000007033441,0.0000145134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2400752,"threshold_uncertainty_score":0.5976474,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3164315881","doi":"10.2217/cer-2021-0069","title":"Propensity score matching versus coarsened exact matching in observational comparative effectiveness research","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"London Health Sciences Centre; Western University","funders":"Physicians' Services Incorporated Foundation","keywords":"Propensity score matching; Observational study; Medicine; Randomized controlled trial; Matching (statistics); Comparative effectiveness research; Clinical trial; Balance (ability); Statistics; Physical therapy; Internal medicine; Mathematics; Alternative medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.8095129096967779,"gpt":0.6082277517660837,"spread":0.2012851579306942,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.02928176,0.0004999183,0.002103795,0.001347871,0.0007234237,0.0003271701,0.0009590239,0.0002756057,0.00008923419],"category_scores_gemma":[0.004235402,0.0004374577,0.0002834203,0.003202508,0.0008391858,0.001529105,0.0007536031,0.004740795,0.00003412241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002393769,"about_ca_system_score_gemma":0.001975587,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001544799,"about_ca_topic_score_gemma":0.0003936029,"domain_scores_codex":[0.9689988,0.02435825,0.001255276,0.000773003,0.003437417,0.00117727],"domain_scores_gemma":[0.9334999,0.05617113,0.0005535347,0.0006323943,0.008841533,0.0003015337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0341129,0.005048009,0.04956798,0.002936326,0.001346356,0.004241399,0.01756214,0.01029143,0.5637065,0.308827,0.0007670129,0.001592958],"study_design_scores_gemma":[0.003841282,0.001532632,0.2669365,0.003891279,0.00002694561,0.0001281122,0.003730098,0.0002630379,0.2498529,0.469249,0.00009842565,0.0004497904],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9661387,0.0003942453,0.02881145,0.0001181287,0.000333752,0.00182129,0.00001428153,0.00005587193,0.002312257],"genre_scores_gemma":[0.9905977,0.00005601946,0.008770002,0.000007142757,0.0002187043,0.000230706,0.00001343288,0.0000574732,0.00004882475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3138535,"threshold_uncertainty_score":0.9998077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113687724","doi":"10.2217/cer.15.34","title":"Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients","year":2015,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Paliperidone Palmitate; Medicine; Schizophrenia (object-oriented programming); Medicaid; Health care; Paliperidone; Formulary; Marginal structural model; Pharmacy; Health economics; Psychiatry; Emergency medicine; Antipsychotic; Internal medicine; Family medicine; Confounding; Public health","retraction":null,"screen_n_in":null,"score":{"opus":0.2815064902716655,"gpt":0.5329407486024871,"spread":0.2514342583308216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00263127,0.0002556017,0.001292826,0.001099898,0.00006712505,0.00003069781,0.0002408795,0.0001128176,0.00002018759],"category_scores_gemma":[0.0012618,0.0001610275,0.0003511803,0.0009896106,0.0003007068,0.0001652184,0.00007572088,0.0012673,0.00003585202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001288433,"about_ca_system_score_gemma":0.001637712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001001539,"about_ca_topic_score_gemma":0.00008364657,"domain_scores_codex":[0.9937563,0.002637513,0.0006476142,0.0002632689,0.002113339,0.0005819434],"domain_scores_gemma":[0.9932244,0.002406569,0.0002336845,0.0003198679,0.003061562,0.0007538976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.440534,0.002727938,0.5529556,0.00005943715,0.0004956253,0.0001748437,0.0002846641,0.0001681717,0.0001376547,0.0002727358,0.0001379861,0.002051341],"study_design_scores_gemma":[0.05090038,0.03903213,0.9070597,0.0004907861,0.00002508273,0.00001645797,0.0001686206,0.0001248044,0.001255877,0.0008144965,0.00001008429,0.0001015746],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980047,0.0003183467,0.00002385766,0.0003051324,0.0002654307,0.0009537876,0.00002682849,0.000005690296,0.00009623353],"genre_scores_gemma":[0.999252,0.00005686801,0.0005394092,0.000004054733,0.00008170161,0.00002300389,0.00001196329,0.00002103936,0.000009969757],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3896337,"threshold_uncertainty_score":0.656651,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3121768136","doi":"10.2217/cer-2020-0187","title":"Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Health care; Logistic regression; Health Information National Trends Survey; Family medicine; Medical prescription; Odds ratio; Population; Odds; Cohort; National Health Interview Survey; Demography; Gerontology; Nursing; Health information; Environmental health; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07384825278749714,"gpt":0.4819782696235688,"spread":0.4081300168360716,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002652029,0.0001537501,0.0005862464,0.0006379317,0.0002731327,0.00004269112,0.000158946,0.00005642245,0.0001215305],"category_scores_gemma":[0.0003960242,0.0001029332,0.00007819301,0.001592682,0.0000437455,0.0002504679,0.00004625015,0.0008593734,0.000005814682],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006236078,"about_ca_system_score_gemma":0.001117393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004353775,"about_ca_topic_score_gemma":0.008619865,"domain_scores_codex":[0.992599,0.004299725,0.0007665699,0.0002438891,0.001695993,0.0003947841],"domain_scores_gemma":[0.9955628,0.001448232,0.0002741812,0.0001941809,0.002125114,0.000395476],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00138232,0.0008513305,0.9815178,0.000188674,0.0001026051,0.0001307093,0.01300748,0.0007963065,0.0001312263,0.00004523847,0.00008909816,0.001757207],"study_design_scores_gemma":[0.005285272,0.007506453,0.9670384,0.0006669784,0.00003377739,0.000005063042,0.01833157,0.0001483088,0.0007704823,0.00006603722,0.00006826584,0.00007941599],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957044,0.0001779164,0.00001322688,0.001589086,0.0002445218,0.002237001,0.00001334277,0.000004255096,0.00001626984],"genre_scores_gemma":[0.9990537,0.000009088674,0.00001674331,0.0005701406,0.0001063991,0.0001938395,0.00003059873,0.00001320318,0.000006246245],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01447943,"threshold_uncertainty_score":0.6581634,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109637262","doi":"10.2217/cer-2020-0079","title":"Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Socioeconomic status; Pancreatic cancer; Logistic regression; Odds ratio; Epidemiology; Internal medicine; Proportional hazards model; Cancer registry; Cancer; Pancreatectomy; Surgery; Demography; Pancreas; Population; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1825159377404781,"gpt":0.5083818008052303,"spread":0.3258658630647522,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000330446,0.0001171804,0.0007737062,0.0001524181,0.00004162336,0.00001010926,0.00005995021,0.00002752621,0.00005755977],"category_scores_gemma":[0.00009562577,0.00006651784,0.0001182503,0.0001724121,0.0001889694,0.0001354168,0.00001812308,0.0001887207,0.000001343349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004827503,"about_ca_system_score_gemma":0.0005745323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005093443,"about_ca_topic_score_gemma":0.00001540745,"domain_scores_codex":[0.9984901,0.0004222339,0.0003066212,0.0001226031,0.0004756791,0.0001827584],"domain_scores_gemma":[0.9973798,0.0009468276,0.0002905202,0.00007993777,0.001110354,0.0001925753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01349719,0.0002730323,0.9790118,0.0001110665,0.001053027,0.000005678148,0.001984657,0.001661595,0.001152063,0.00002265329,0.00005677103,0.001170431],"study_design_scores_gemma":[0.005044497,0.01919684,0.9684307,0.0002718458,0.0000957895,0.000001550248,0.0004664076,0.000118683,0.006281762,0.00003242723,0.00001121096,0.00004827907],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986255,0.0004678107,0.00006251829,0.0001084765,0.00001460684,0.0005484011,0.00003674952,0.000001529062,0.0001344229],"genre_scores_gemma":[0.9997339,0.0001274374,0.00006520952,0.000009595131,0.00003232401,0.00001572301,0.000002985852,0.000007103788,0.000005696896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01892381,"threshold_uncertainty_score":0.2712519,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2747351937","doi":"10.2217/cer-2017-0043","title":"Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits","year":2017,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Paliperidone Palmitate; Medicine; Antipsychotic; Schizophrenia (object-oriented programming); Medicaid; Paliperidone; Risperidone; Psychiatry; Internal medicine; Health care","retraction":null,"screen_n_in":null,"score":{"opus":0.1177252280232934,"gpt":0.4255221851048258,"spread":0.3077969570815324,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001673698,0.0002992666,0.001100433,0.0006206487,0.0004363847,0.0001349022,0.0002945267,0.00009953303,0.00002873343],"category_scores_gemma":[0.0003618606,0.0001888896,0.0000906466,0.0003823287,0.000989665,0.0004376075,0.00007481151,0.001102925,0.00000613813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00079253,"about_ca_system_score_gemma":0.000740141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002656968,"about_ca_topic_score_gemma":0.01224926,"domain_scores_codex":[0.9964036,0.0009870129,0.0004839458,0.0003785147,0.001145943,0.0006010022],"domain_scores_gemma":[0.9960036,0.001960753,0.0004598441,0.0003690853,0.000773145,0.0004335665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2198215,0.0006522058,0.775852,0.00003108357,0.0009166228,0.0001366729,0.0001892281,0.0002710166,0.00002998148,0.0003179071,0.000006461567,0.001775331],"study_design_scores_gemma":[0.0585917,0.005519805,0.9326856,0.001403433,0.00009759178,0.000009567,0.0001002923,0.0008486935,0.0001872152,0.0003750014,0.000002809254,0.0001783118],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982867,0.000206126,0.0000168771,0.0001974601,0.0001524256,0.0009788814,0.00002018758,0.000008340201,0.0001330503],"genre_scores_gemma":[0.9990093,0.0002662834,0.0006110135,0.000001512649,0.00002940972,0.00002398822,0.00001160025,0.00002966108,0.00001720566],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1612298,"threshold_uncertainty_score":0.7702694,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2770256141","doi":"10.2217/cer-2017-0011","title":"Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Trimetazidine; Medicine; Tolerability; Internal medicine; Cardiology; Angina; Diabetes mellitus; Type 2 diabetes; Coronary artery disease; Ischemia; Adverse effect; Unstable angina; Myocardial infarction; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.03753972083842771,"gpt":0.3606793636673458,"spread":0.3231396428289181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003386379,0.000155572,0.001043115,0.0004577249,0.0001925836,0.00004578389,0.0001052353,0.00007369739,0.00001073101],"category_scores_gemma":[0.0004964762,0.0001013449,0.00009919483,0.0003247894,0.0004355211,0.0002861723,0.00008848382,0.0005418816,9.454352e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001385127,"about_ca_system_score_gemma":0.0001852943,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005047847,"about_ca_topic_score_gemma":0.000003399879,"domain_scores_codex":[0.9976012,0.001006008,0.0002685112,0.0002072962,0.0006709959,0.0002459589],"domain_scores_gemma":[0.9967945,0.001084111,0.0002280844,0.0002681284,0.001479395,0.0001457711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009012812,0.0002827068,0.9687606,0.0004952101,0.0005901213,0.00001586944,0.0001583773,0.00003632987,0.01958585,0.00001908369,0.00002114291,0.001021957],"study_design_scores_gemma":[0.008692688,0.002349946,0.9184963,0.0009812339,0.00009164023,0.00001193862,0.00007976197,0.00002890293,0.06895054,0.00001630822,0.0002090686,0.0000917135],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974182,0.001462572,0.00008831695,0.00001727358,0.0001231489,0.0006845324,0.000005383247,0.000002967151,0.0001975607],"genre_scores_gemma":[0.9996232,0.0002536219,0.00004447153,8.557028e-7,0.00004347899,0.000005917611,0.000002535112,0.00001382593,0.00001205157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05026428,"threshold_uncertainty_score":0.4132724,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2803925386","doi":"10.2217/cer-2018-0015","title":"Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis","year":2018,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Cinacalcet; Observational study; Randomized controlled trial; Discontinuation; Hazard ratio; Meta-analysis; Internal medicine; MEDLINE; Dialysis; Intensive care medicine; Relative risk; Parathyroidectomy; Secondary hyperparathyroidism; Confidence interval; Parathyroid hormone","retraction":null,"screen_n_in":null,"score":{"opus":0.1963978398121837,"gpt":0.5228953080177915,"spread":0.3264974682056078,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002902849,0.0006653477,0.01347418,0.003108272,0.00008205698,0.00005474214,0.0003297259,0.0002939483,0.00001943101],"category_scores_gemma":[0.0008934151,0.000363964,0.00384639,0.003918539,0.0003108054,0.0001429194,0.0001231558,0.001367472,0.000008744639],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003425874,"about_ca_system_score_gemma":0.0003123219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008078222,"about_ca_topic_score_gemma":0.00001344311,"domain_scores_codex":[0.9893326,0.006825604,0.001496686,0.0005363982,0.001393967,0.0004147553],"domain_scores_gemma":[0.9895918,0.006413186,0.001211454,0.0005262868,0.001972478,0.0002847434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001251693,0.01037659,0.05907398,0.1682733,0.7421181,0.001300246,0.0005707949,0.000005066036,0.000002708483,0.00005349964,0.0007502433,0.01622376],"study_design_scores_gemma":[0.004936966,0.006994376,0.1428629,0.04166967,0.7992002,0.00004788455,0.000006990066,0.000003493878,0.00009950428,0.0000611421,0.003610869,0.0005060459],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006757737,0.9897135,0.00007799054,0.00002597093,0.00004886178,0.003230406,0.00005729586,0.000002827952,0.00008540312],"genre_scores_gemma":[0.02672397,0.9727657,0.00004603389,0.00001850871,0.00003692951,0.0002273879,0.00006183636,0.00003410372,0.00008546568],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1266037,"threshold_uncertainty_score":0.9998812,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4393871536","doi":"10.57264/cer-2023-0178","title":"The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Arthur B. McDonald-Canadian Astroparticle Physics Research Institute; Wilfrid Laurier University; Canadian Institute for Health Information","funders":"","keywords":"Medicine; Reimbursement; Internal medicine; Willingness to pay; Agency (philosophy); Oncology; Health care","retraction":null,"screen_n_in":null,"score":{"opus":0.659831116409612,"gpt":0.6654963885408027,"spread":0.005665272131190724,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08046347,0.0002694378,0.003462629,0.001303307,0.0004469361,0.00007924587,0.0006385177,0.0002138705,0.000009194266],"category_scores_gemma":[0.004553861,0.0001626708,0.000439829,0.001240774,0.0002832031,0.0001848941,0.00006737346,0.001099928,0.000007083652],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.005496803,"about_ca_system_score_gemma":0.006161341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005010289,"about_ca_topic_score_gemma":0.001165276,"domain_scores_codex":[0.990194,0.003926283,0.004763631,0.0004062681,0.0002172347,0.0004925597],"domain_scores_gemma":[0.9783533,0.01545515,0.00470688,0.0003918048,0.0009382992,0.0001546148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005896171,0.0007687265,0.0002245753,0.3222046,0.003312038,0.000001072364,0.008078473,0.0001859412,0.000002626045,0.05498814,0.2458171,0.3638271],"study_design_scores_gemma":[0.0007165404,0.002904468,0.0002016108,0.08410668,0.00006553976,0.00001508812,0.002184713,0.0002282574,0.00000438573,0.01259737,0.8967496,0.0002257555],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006093803,0.9675208,0.0002712492,0.0217208,0.0004265938,0.008356116,0.0009082886,0.00000461763,0.0001821295],"genre_scores_gemma":[0.01139672,0.9864465,0.0002656892,0.00006694497,0.00008796146,0.001603151,0.00004646216,0.00003103494,0.00005550886],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6509324,"threshold_uncertainty_score":0.9994728,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3174892139","doi":"10.2217/cer-2020-0278","title":"Gender, socioeconomic status and emergency department visits among cancer survivors in the USA: a population-based study","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Emergency department; Socioeconomic status; Logistic regression; Demography; Population; Odds ratio; Cohort; Cohort study; Environmental health; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.2850653871005384,"gpt":0.5466509751092106,"spread":0.2615855880086722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002662857,0.0001305111,0.0006131161,0.0002863429,0.000108997,0.00002212992,0.0001061786,0.00004364002,0.0001318031],"category_scores_gemma":[0.0002238138,0.00008874955,0.0001031801,0.0004201664,0.00007332749,0.0001256463,0.00003931021,0.0004935825,0.000002487212],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003663068,"about_ca_system_score_gemma":0.0005126728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002031089,"about_ca_topic_score_gemma":0.0102849,"domain_scores_codex":[0.9953672,0.00304737,0.0004617599,0.0001922267,0.0006602202,0.0002712696],"domain_scores_gemma":[0.996507,0.002035027,0.0001995659,0.0001525069,0.0009954359,0.0001104396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000687095,0.0006965451,0.9904886,0.0001513967,0.0002845539,0.0001035769,0.005708687,0.0008960647,0.0006382244,0.00004105622,0.00002755321,0.0002766486],"study_design_scores_gemma":[0.002122898,0.0008031459,0.986658,0.0002990299,0.0000527872,0.000002905718,0.006495235,0.0002192049,0.003018203,0.0001468897,0.0001079095,0.00007383225],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936087,0.005277392,0.00009129354,0.00007811261,0.0001261468,0.0006773943,0.00000864354,0.00000161965,0.0001307297],"genre_scores_gemma":[0.999103,0.0006635308,0.00004821811,0.000008986865,0.00008343347,0.00006621828,0.000004827602,0.000008680236,0.00001315203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008253806,"threshold_uncertainty_score":0.5739213,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3209536742","doi":"10.2217/cer-2021-0018","title":"Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy","year":2021,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute for Health and Care Research; PTC Therapeutics","keywords":"Deflazacort; Medicine; Prednisone; Nonsense mutation; Duchenne muscular dystrophy; Prednisolone; Muscular dystrophy; Internal medicine; Placebo; Pediatrics; Physical therapy; Mutation; Genetics; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.3540440919860048,"gpt":0.5138161215238461,"spread":0.1597720295378413,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001816603,0.0004006736,0.003087611,0.0005626178,0.00007994416,0.00002303099,0.0003870963,0.0003193234,0.00002442415],"category_scores_gemma":[0.0003949305,0.000269424,0.001033928,0.0007753973,0.0003895673,0.00001882723,0.0001521064,0.0007638673,0.000002802013],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009632146,"about_ca_system_score_gemma":0.0009646756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002405345,"about_ca_topic_score_gemma":0.00002344426,"domain_scores_codex":[0.9913456,0.006258987,0.000885451,0.0004716689,0.0006938265,0.0003444753],"domain_scores_gemma":[0.9954694,0.001054436,0.000873174,0.0004544012,0.00204295,0.0001056218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1779575,0.0234947,0.005026225,0.06454468,0.4491936,0.001373885,0.001702503,0.03352825,0.04067345,0.0004308148,0.001425726,0.2006487],"study_design_scores_gemma":[0.1285402,0.1719175,0.134726,0.05464531,0.1493248,0.0004790472,0.002474462,0.000161817,0.08663354,0.0008836584,0.2609994,0.009214339],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2793907,0.7193531,0.000400091,0.000002611524,0.00008668179,0.0006793549,0.00003398993,0.000001153924,0.00005227064],"genre_scores_gemma":[0.5380819,0.4611542,0.0002598854,0.000002104128,0.00008101082,0.0001160615,0.0002578973,0.00003791777,0.000009062615],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.2998688,"threshold_uncertainty_score":0.9999758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2806016224","doi":"10.2217/cer-2017-0029","title":"Comparison of EQ-5D and SF-36 in untreated patients with symptoms of intermittent claudication","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"GlaxoSmithKline (Canada); University of Alberta","funders":"Universiteit Maastricht","keywords":"Medicine; EQ-5D; Valuation (finance); Intermittent claudication; Quality of life (healthcare); Physical therapy; Tariff; Quality-adjusted life year; Health related quality of life; Arterial disease; Disease; Finance; Surgery; Internal medicine; Cost effectiveness","retraction":null,"screen_n_in":null,"score":{"opus":0.1271241282527948,"gpt":0.4342501851668769,"spread":0.3071260569140821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001041614,0.0001205471,0.0007298394,0.0005923816,0.00004161631,0.00001185493,0.0001279827,0.00003841201,0.00003741182],"category_scores_gemma":[0.000091174,0.000081883,0.00005178777,0.0005787843,0.0005731136,0.0001502333,0.00008227893,0.0002926683,0.00000322276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002174058,"about_ca_system_score_gemma":0.0001216937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002998601,"about_ca_topic_score_gemma":0.00002087571,"domain_scores_codex":[0.9974332,0.0008667324,0.0005259016,0.0001607518,0.0008199134,0.0001935365],"domain_scores_gemma":[0.9969839,0.0004072046,0.0003650672,0.000167374,0.00195322,0.0001231762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01147223,0.001727749,0.9710959,0.0003461072,0.0002894004,0.000008798715,0.001514273,0.00005772206,0.007022046,0.00008407931,0.00008651989,0.006295219],"study_design_scores_gemma":[0.004836746,0.009989363,0.9618424,0.001516145,0.00005475666,0.000003676242,0.0004304429,0.001009356,0.02011138,0.0000817082,0.00006152434,0.00006247162],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979191,0.0001819855,0.0004756876,0.00006269068,0.00003414647,0.0007344367,0.000003820992,0.000002729092,0.0005854429],"genre_scores_gemma":[0.9998057,0.000007927373,0.0001049189,0.000005930999,0.00003398138,0.00001517237,0.000004913555,0.000008574144,0.00001285849],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01308934,"threshold_uncertainty_score":0.3339092,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386439153","doi":"10.57264/cer-2023-0075","title":"Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Diabetes Management and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Glycemic; Glycated hemoglobin; Hypoglycemia; Type 2 diabetes; Diabetes mellitus; Continuous glucose monitoring; Type 1 diabetes; Quality-adjusted life year; Internal medicine; Blood Glucose Self-Monitoring; Insulin; Cost effectiveness; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.07002837368940106,"gpt":0.3832770973235926,"spread":0.3132487236341915,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00445935,0.0002075739,0.001260825,0.001303372,0.00006114536,0.000022714,0.0003220044,0.0000754323,0.00002067669],"category_scores_gemma":[0.0005919366,0.0001613683,0.00008015092,0.003995682,0.0001654374,0.0001913909,0.0001754425,0.0009059036,0.00000540869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006968417,"about_ca_system_score_gemma":0.001875481,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04794907,"about_ca_topic_score_gemma":0.01771643,"domain_scores_codex":[0.9951612,0.001552902,0.0006886537,0.0002660788,0.001643063,0.0006881155],"domain_scores_gemma":[0.9930202,0.004195068,0.0002861641,0.0002836302,0.002010776,0.000204127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008227251,0.0007694546,0.9331585,0.0008041846,0.000618482,0.0003108004,0.0006243668,0.0005436099,0.05344945,0.000003644793,0.00002343339,0.001466828],"study_design_scores_gemma":[0.006311823,0.002298152,0.7256083,0.001494876,0.00005951033,0.000001143666,0.001338514,0.001107594,0.2616703,0.000009879885,0.00001109188,0.00008881511],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972177,0.0008072259,6.460196e-7,0.00002751884,0.0001997982,0.001128165,0.000006302979,0.00001225931,0.0006003487],"genre_scores_gemma":[0.9992157,0.0005205401,0.00006968028,2.548319e-7,0.00008789967,0.00004059058,0.000005492007,0.00002348423,0.00003634527],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2082209,"threshold_uncertainty_score":0.9886184,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3129342924","doi":"10.2217/cer-2020-0272","title":"Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Fulvestrant; Palbociclib; Hazard ratio; Oncology; Internal medicine; Breast cancer; Hormone receptor; Gynecology; Cancer; Confidence interval; Metastatic breast cancer; Estrogen receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.09824933317196574,"gpt":0.4667089789174239,"spread":0.3684596457454581,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002000812,0.0003686512,0.002078515,0.0006881967,0.0001688586,0.00004304308,0.000233865,0.0001746836,0.0001290349],"category_scores_gemma":[0.0003411204,0.0003193815,0.0002066104,0.001871741,0.0007754243,0.0005466336,0.0001754925,0.001757408,0.000006227174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001067495,"about_ca_system_score_gemma":0.001005117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002256474,"about_ca_topic_score_gemma":0.0002426802,"domain_scores_codex":[0.9937466,0.002837225,0.0009687394,0.0004907884,0.001344164,0.000612463],"domain_scores_gemma":[0.9903334,0.005130684,0.0006492436,0.0002528753,0.003320973,0.0003128178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.1219396,0.002454155,0.139434,0.0008614711,0.002173362,0.0003661405,0.0203814,0.002741996,0.651737,0.0004646647,0.00008775824,0.05735853],"study_design_scores_gemma":[0.01666573,0.002169416,0.6764085,0.002477426,0.00008861152,0.0002150316,0.01105916,0.0001397871,0.2896492,0.0007310045,0.0001469726,0.0002492066],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872203,0.01022177,0.0004139695,0.0004665058,0.000239818,0.0008151878,0.00009063562,0.00001504869,0.0005167365],"genre_scores_gemma":[0.997011,0.000862218,0.001748677,0.0000151759,0.0001713001,0.00008087252,0.000009863199,0.00004722125,0.00005365565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5369745,"threshold_uncertainty_score":0.9999259,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2794986206","doi":"10.2217/cer-2017-0092","title":"Analysis of indirect treatment comparisons in national health technology assessments and requirements for industry submissions","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Scope (computer science); Health technology; Medicine; Comparative effectiveness research; Alternative medicine; Health care; Computer science; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.8138658705718702,"gpt":0.6792615665071889,"spread":0.1346043040646813,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03192726,0.0001291002,0.001755422,0.004051713,0.0002290019,0.00003269888,0.0002172455,0.0001687379,0.00005141835],"category_scores_gemma":[0.001742424,0.0001309089,0.0001234543,0.00178911,0.0003031157,0.0002696611,0.00005191001,0.0003891785,0.000008484097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001928642,"about_ca_system_score_gemma":0.0009854165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002372711,"about_ca_topic_score_gemma":0.0003539038,"domain_scores_codex":[0.994746,0.00178693,0.00254509,0.0003012975,0.0002744222,0.0003463172],"domain_scores_gemma":[0.9925666,0.004056441,0.002101465,0.0001705457,0.0009492891,0.0001556715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002866371,0.0005316396,0.977611,0.0001342445,0.001353686,5.839131e-7,0.001536775,0.0004565125,0.00006318513,0.01678554,0.0009914761,0.0002487098],"study_design_scores_gemma":[0.002598398,0.002906449,0.9694702,0.0002950451,0.00002669173,0.000003268309,0.002487269,0.009374471,0.0004956692,0.009002526,0.003206567,0.000133453],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888721,0.001130617,0.005146954,0.003133161,0.0001260149,0.0009456281,0.0001549789,0.000003824875,0.0004866869],"genre_scores_gemma":[0.9979698,0.00006371577,0.001648423,0.00006695991,0.00008445891,0.0001116337,0.00001032495,0.000008546357,0.00003613426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03018484,"threshold_uncertainty_score":0.9968346,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401518102","doi":"10.57264/cer-2024-0061","title":"The maze of real-world evidence frameworks: from a desert to a jungle! An environmental scan and comparison across regulatory and health technology assessment agencies","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Jungle; Medicine; Desert (philosophy); Real world evidence; Environmental resource management; Environmental planning; Geography; Archaeology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.5807403555675743,"gpt":0.6226783898007007,"spread":0.04193803423312636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04290909,0.000165706,0.001198222,0.0006572548,0.0004268856,0.0002520836,0.0003868188,0.0001301164,0.00002168845],"category_scores_gemma":[0.0007069887,0.0001457613,0.00006834028,0.0005418662,0.0006418712,0.000564408,0.0002169829,0.001013455,0.00001871691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001781576,"about_ca_system_score_gemma":0.0005380318,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009649515,"about_ca_topic_score_gemma":0.001093111,"domain_scores_codex":[0.9940832,0.002462851,0.002242502,0.0004384238,0.0003422039,0.0004307815],"domain_scores_gemma":[0.9899529,0.008284068,0.0009927591,0.0003500447,0.0001454337,0.0002748508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004596878,0.0003168923,0.8677408,0.001012542,0.0005945507,0.00001034831,0.04004597,0.001215115,0.001017366,0.07813918,0.002377489,0.00707006],"study_design_scores_gemma":[0.0003540885,0.001300823,0.948872,0.001666086,0.000005680251,0.000008305125,0.01975463,0.007798415,0.0003210215,0.01735975,0.002407834,0.0001513367],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9533449,0.03201989,0.003310074,0.01013529,0.0002331803,0.0008267199,0.00007056355,0.00001015594,0.00004915467],"genre_scores_gemma":[0.9964691,0.00131926,0.001867927,0.0001057314,0.0001220415,0.00005658836,0.000002053696,0.00001715838,0.00004010556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08113123,"threshold_uncertainty_score":0.9855265,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2905207641","doi":"10.2217/cer-2018-0033","title":"Early cost–effectiveness modeling for better decisions in public research investment of personalized medicine technologies","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Investment (military); Risk analysis (engineering); Cost effectiveness; Personalized medicine; Process (computing); Medicine; Key (lock); Health care; Cost–benefit analysis; Comparative effectiveness research; Health technology; Investment decisions; Public health; Business; Computer science; Economics; Finance; Computer security","retraction":null,"screen_n_in":null,"score":{"opus":0.8503316042240933,"gpt":0.6303314722597517,"spread":0.2200001319643415,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1662492,0.000229994,0.002144864,0.004185122,0.0004807084,0.00008995826,0.0009200101,0.000241666,0.00006061694],"category_scores_gemma":[0.02920014,0.0002150753,0.0001986869,0.001858203,0.001695747,0.0007619068,0.0002307826,0.00110037,0.00008130749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001911541,"about_ca_system_score_gemma":0.0007137837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004032941,"about_ca_topic_score_gemma":0.00008824429,"domain_scores_codex":[0.9859517,0.008041479,0.003662929,0.0005857001,0.0008038632,0.0009543396],"domain_scores_gemma":[0.9600911,0.03366878,0.001325399,0.0005092957,0.00420233,0.00020309],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.00580373,0.001736079,0.1411585,0.001820263,0.001010256,0.00001638593,0.02431715,0.00275273,0.003136412,0.8100178,0.005753364,0.00247736],"study_design_scores_gemma":[0.01330235,0.008239018,0.1268968,0.005131803,0.00001714393,0.00002456697,0.02122756,0.04984622,0.00321177,0.7574338,0.01407401,0.0005949144],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9295493,0.003321155,0.05543681,0.007464875,0.0003157859,0.002885306,0.00004134307,0.00001385777,0.0009715987],"genre_scores_gemma":[0.996941,0.0001855037,0.001778266,0.00009475552,0.0003149413,0.0006258027,0.000004396476,0.00003042992,0.00002494994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.137049,"threshold_uncertainty_score":0.9789773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2990463671","doi":"10.2217/cer-2019-0111","title":"The lateral and medial approach in total arthroplasty for valgus knee: a meta-analysis of current literature","year":2019,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Valgus; Total knee arthroplasty; Valgus deformity; Meta-analysis; Range of motion; Cochrane Library; Osteoarthritis; Physical therapy; Arthroplasty; Randomized controlled trial; Physical medicine and rehabilitation; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3371849787735286,"gpt":0.5177686102147684,"spread":0.1805836314412398,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00695743,0.0005048915,0.008502195,0.00217098,0.0001368112,0.0001261368,0.0002580223,0.0002591626,0.00001806738],"category_scores_gemma":[0.0006106414,0.000249118,0.003620329,0.002535045,0.0005212784,0.0001955627,0.0001937546,0.002298491,0.000003968448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002760519,"about_ca_system_score_gemma":0.0009028126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003410685,"about_ca_topic_score_gemma":0.00001002294,"domain_scores_codex":[0.9916636,0.004489563,0.001449934,0.0004601218,0.001408032,0.0005287239],"domain_scores_gemma":[0.9830841,0.01372912,0.0009551662,0.0004378473,0.001587498,0.0002062275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01034464,0.002642653,0.003299003,0.1054378,0.5533399,0.0001748038,0.005373118,0.0005669314,0.00002988394,0.002361972,0.0005593546,0.3158699],"study_design_scores_gemma":[0.01379355,0.01087007,0.04355738,0.02232421,0.5217875,0.001455463,0.0005405519,0.002109677,0.00004449463,0.0003680832,0.3818582,0.001290811],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008550593,0.9870493,0.0002758417,0.00003065799,0.0003582207,0.003539083,0.0001394358,0.000003311028,0.00005359622],"genre_scores_gemma":[0.0524921,0.9462594,0.00021912,0.000001946401,0.0002749386,0.0004438472,0.00006737682,0.00005103542,0.0001901971],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3812988,"threshold_uncertainty_score":0.9999961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2969452269","doi":"10.2217/cer-2019-0091","title":"Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Duchesnay (Canada)","funders":"","keywords":"Medicine; Pharmacy; Menopause; Healthcare system; Internal medicine; Gynecology; Health care; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04406549513679099,"gpt":0.4001549787219962,"spread":0.3560894835852053,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001787156,0.0001670566,0.000389974,0.0002137447,0.00006246676,0.00003653669,0.0002433311,0.0001756519,0.0000143044],"category_scores_gemma":[0.0001044296,0.0001354253,0.00004809282,0.0003152608,0.000266155,0.00001910085,0.0001581876,0.000694386,0.00003183993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001441165,"about_ca_system_score_gemma":0.0002687446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002692411,"about_ca_topic_score_gemma":0.00001114734,"domain_scores_codex":[0.9973059,0.001358991,0.0002727998,0.0002701423,0.0004338022,0.0003583887],"domain_scores_gemma":[0.9984888,0.0005875039,0.0001183429,0.0001883449,0.0004514681,0.0001655609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01329972,0.0002569991,0.04878306,0.00005853878,0.0002593108,0.0001131007,0.000138216,0.0009341029,0.9318978,0.0006502279,0.000114365,0.003494588],"study_design_scores_gemma":[0.01311301,0.03935749,0.163472,0.000603614,0.00003330163,0.0003296595,0.00102764,0.0006912738,0.7795254,0.0002013108,0.00120086,0.0004444748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924457,0.005469431,0.0002039562,0.00002298705,0.0002366926,0.0004405549,0.000002804908,0.000002233772,0.001175614],"genre_scores_gemma":[0.9994962,0.0002508344,0.00008991958,0.000005117935,0.00008390084,0.00001306586,0.000005848392,0.00001426177,0.00004083676],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1523724,"threshold_uncertainty_score":0.5522483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143296285","doi":"10.2217/cer.11.6","title":"Clinical practice change requires more than comparative effectiveness evidence: abdominal aortic aneurysm management in the USA","year":2012,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Aortic aneurysm repair treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Abdominal aortic aneurysm; Endovascular aneurysm repair; Comparative effectiveness research; Aortic aneurysm; Abdominal surgery; Clinical trial; Randomized controlled trial; Surgery; General surgery; Health care; Aneurysm; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.432308873191544,"gpt":0.5887352008087636,"spread":0.1564263276172196,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.02956927,0.000467246,0.001708785,0.0007767773,0.0003298193,0.0000975658,0.0006907762,0.0001913862,0.00004750833],"category_scores_gemma":[0.002103486,0.0002902666,0.0004590323,0.001607879,0.00104836,0.001822166,0.0002741523,0.002315634,0.0001429323],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008886926,"about_ca_system_score_gemma":0.0003408382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001422802,"about_ca_topic_score_gemma":0.00001670904,"domain_scores_codex":[0.9739755,0.01998758,0.00138488,0.0005302724,0.003044094,0.0010777],"domain_scores_gemma":[0.9691918,0.02714844,0.0007759723,0.000699996,0.001713724,0.0004699964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02572764,0.0066142,0.9423473,0.0008434973,0.001476936,0.004366251,0.01212165,0.00005035575,0.0007047864,0.0006241055,0.0004097663,0.004713444],"study_design_scores_gemma":[0.004360094,0.005220209,0.9752567,0.002347589,0.0005514662,0.002746247,0.007162066,0.000297721,0.001153927,0.0001255352,0.0005436284,0.0002348017],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874753,0.004314841,0.0006352029,0.0006527955,0.0004946697,0.004370281,0.000003026624,0.00001476084,0.002039163],"genre_scores_gemma":[0.9967782,0.0004998411,0.001060747,0.0001434214,0.0008242772,0.000601508,0.000003464512,0.00003212803,0.00005640045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03290934,"threshold_uncertainty_score":0.9999861,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3084779451","doi":"10.2217/cer-2020-0155","title":"Patient and caregiver experiences at a specialized primary care center for autistic adults","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal College of Physicians and Surgeons of Canada","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Health care; Medical home; Autism; Special needs; Patient satisfaction; Population; Family medicine; Healthcare delivery; Primary care; Psychiatry; Nursing; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1167764242980788,"gpt":0.4300710642970473,"spread":0.3132946399989685,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003328413,0.0001498817,0.0005795343,0.0001651185,0.0001723495,0.0000570077,0.0001155347,0.00003765477,0.0000925587],"category_scores_gemma":[0.0001476238,0.000112934,0.0001369284,0.0002290636,0.0003332205,0.0001556753,0.0001707729,0.0002485224,0.000006351223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006020902,"about_ca_system_score_gemma":0.0003265172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005714731,"about_ca_topic_score_gemma":0.000004345239,"domain_scores_codex":[0.997874,0.0005014935,0.0002949214,0.0002582498,0.0007889307,0.0002823942],"domain_scores_gemma":[0.9978697,0.0006671367,0.000144948,0.0001075768,0.0009589777,0.0002516672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"qualitative","study_design_gemma":"observational","study_design_scores_codex":[0.2108252,0.001858845,0.04509832,0.02642529,0.002319074,0.001906959,0.644619,0.0003538041,0.01030078,0.002046956,0.02845742,0.02578832],"study_design_scores_gemma":[0.05187946,0.02940655,0.5062279,0.00604604,0.0004004772,0.000187407,0.3186673,0.001702173,0.0141698,0.0003963617,0.07019993,0.0007166381],"study_design_candidate":"qualitative","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910573,0.002829745,0.0005665697,0.0003422701,0.000145588,0.001572483,0.00002837533,0.000009219005,0.003448487],"genre_scores_gemma":[0.9993231,0.00005900428,0.0001225534,0.00006015393,0.0002542197,0.0001252422,0.00002084697,0.00001243835,0.00002244105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4611295,"threshold_uncertainty_score":0.4605313,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390743877","doi":"10.57264/cer-2023-0147","title":"Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Ontario; University of Toronto; McMaster University; Impact","funders":"","keywords":"Robustness (evolution); Missing data; External validity; Medicine; Confounding; Sample size determination; Population; Clinical trial; Data collection; Computer science; Statistics; Machine learning","retraction":null,"screen_n_in":null,"score":{"opus":0.9834323930954177,"gpt":0.8240222415215248,"spread":0.1594101515738929,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3342595,0.0008316274,0.01612965,0.005687937,0.0001875616,0.0003724036,0.002769324,0.0006265301,0.00001628946],"category_scores_gemma":[0.1218056,0.0005502163,0.004771945,0.005079334,0.001445154,0.0006514066,0.0007213948,0.006224374,0.000008687379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001490538,"about_ca_system_score_gemma":0.004474231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001030114,"about_ca_topic_score_gemma":0.0004377239,"domain_scores_codex":[0.9050604,0.08073597,0.009428098,0.001513695,0.002095305,0.001166508],"domain_scores_gemma":[0.5938081,0.3951927,0.00501001,0.001430326,0.00411909,0.000439779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.04622059,0.006351131,0.006434885,0.07784056,0.08507364,0.0005796313,0.0008958925,0.0002499938,0.0000436797,0.07763619,0.006389215,0.6922846],"study_design_scores_gemma":[0.01571563,0.0225216,0.001887909,0.1729441,0.06010994,0.00008034999,0.001521869,0.06715553,0.0000810456,0.4481828,0.2068132,0.002986006],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008893286,0.5295447,0.4598588,0.00003116523,0.0003551992,0.008582532,0.000679114,0.00002904354,0.00003008884],"genre_scores_gemma":[0.001941532,0.8800173,0.1154974,0.000004369427,0.001170356,0.001052412,0.00007208915,0.0001683322,0.00007618614],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6892986,"threshold_uncertainty_score":0.9996949,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2808685910","doi":"10.2217/cer-2017-0090","title":"Examples of dramatic failures and their effectiveness in modern surgical disciplines: can we learn from our mistakes?","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Subspecialty; Skepticism; Medicine; Craft; Engineering ethics; Health care; Curiosity; Epistemology; Psychology; Law; Engineering; Pathology; Social psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.1159267352859663,"gpt":0.4303357293267681,"spread":0.3144089940408018,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005142687,0.0002950499,0.00229,0.0006389524,0.0001340942,0.00006274694,0.0002332591,0.0001567423,0.0000206978],"category_scores_gemma":[0.0006362733,0.0001844003,0.0003933166,0.000685352,0.0006570877,0.0001669035,0.00008738426,0.000851433,0.000004314648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002116753,"about_ca_system_score_gemma":0.0003609557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003968022,"about_ca_topic_score_gemma":0.0001826205,"domain_scores_codex":[0.9934061,0.004151602,0.0006938965,0.0003462543,0.0009541647,0.0004480208],"domain_scores_gemma":[0.9842873,0.01370389,0.0002495688,0.0002820518,0.001180052,0.0002971444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03754331,0.002194901,0.8026959,0.002366179,0.001880657,0.00157538,0.02727602,0.0004578683,0.09977922,0.003079757,0.00004493488,0.02110592],"study_design_scores_gemma":[0.007540936,0.002680548,0.9201108,0.003134155,0.00008087998,0.0003569938,0.01084619,0.00134932,0.0490994,0.00332438,0.001222143,0.0002542971],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947305,0.002330942,0.0007365283,0.0007222685,0.00009939995,0.0007418922,0.00001403174,0.000008224845,0.0006162564],"genre_scores_gemma":[0.9993184,0.0001181681,0.0001161811,0.000004712617,0.0003255807,0.00002862332,0.000004759311,0.00002460399,0.00005895758],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1174149,"threshold_uncertainty_score":0.7519625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403139133","doi":"10.57264/cer-2024-0064","title":"Use of transportability methods for real-world evidence generation: a review of current applications","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Context (archaeology); Medicine; Weighting; Data science; Medical physics; Computer science; Geography","retraction":null,"screen_n_in":null,"score":{"opus":0.9525799695547456,"gpt":0.7544126675334183,"spread":0.1981673020213273,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.1255342,0.0003803102,0.007662899,0.001682856,0.0001330958,0.00006622643,0.0007368982,0.0001755462,0.00009186827],"category_scores_gemma":[0.007461565,0.0003440621,0.001515027,0.001826254,0.0003383091,0.0006105845,0.00007668346,0.001072591,0.0000474098],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001493422,"about_ca_system_score_gemma":0.002678501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001029877,"about_ca_topic_score_gemma":0.00003993278,"domain_scores_codex":[0.9760545,0.01170495,0.01077365,0.000687188,0.0004033679,0.000376355],"domain_scores_gemma":[0.9508923,0.03727495,0.008138099,0.0008166606,0.002666326,0.0002116653],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006550793,0.0003765177,0.0001685094,0.8381876,0.0008624016,5.414435e-7,0.000351636,0.00004160142,0.00000309689,0.05887531,0.006168086,0.09489922],"study_design_scores_gemma":[0.0001546484,0.0002737221,0.0001425262,0.1838269,0.0003539175,0.000005214696,0.0000191184,0.0002282521,0.00001675227,0.003598124,0.8111621,0.000218782],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002988766,0.9064379,0.08526436,0.00033533,0.0005019049,0.006807347,0.0005530386,0.000005793846,0.00006446763],"genre_scores_gemma":[0.0001115259,0.9870557,0.009898724,0.00002255313,0.0005424768,0.00222065,0.00005019069,0.00004273656,0.00005549808],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.804994,"threshold_uncertainty_score":0.9999011,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2909436531","doi":"10.2217/cer-2018-0073","title":"A cost–utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Insulin glargine; Dulaglutide; Type 2 diabetes; Diabetes mellitus; Internal medicine; Insulin; Exenatide; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.1614136600299384,"gpt":0.457361692122425,"spread":0.2959480320924865,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00267214,0.0001590423,0.001218033,0.0008987249,0.00003710423,0.00001446052,0.0001862271,0.0000445351,0.0001266044],"category_scores_gemma":[0.000308284,0.0001157702,0.000219431,0.001912316,0.00007911252,0.000111171,0.00005212449,0.0003365557,0.000005628061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008712355,"about_ca_system_score_gemma":0.001418473,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02426006,"about_ca_topic_score_gemma":0.04829093,"domain_scores_codex":[0.9974133,0.0006977532,0.000472781,0.0002114965,0.0008348213,0.0003698789],"domain_scores_gemma":[0.9946025,0.003270037,0.000226325,0.000257719,0.00151305,0.0001303787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03967309,0.001303046,0.9311917,0.0003393936,0.009177423,0.00003691881,0.0003287312,0.003467518,0.006445391,0.0002807651,0.0003222367,0.007433753],"study_design_scores_gemma":[0.01343612,0.006376534,0.9311091,0.0002447685,0.0004097506,4.295356e-7,0.0004650815,0.01073881,0.03534467,0.0001402578,0.001632392,0.0001021025],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995166,0.001870753,0.00004689035,0.0001495025,0.0002167502,0.001804838,0.000015443,0.000002789176,0.0007270483],"genre_scores_gemma":[0.9994935,0.0002025948,0.00008604382,0.00001817883,0.00003721516,0.00005132173,0.00002513722,0.00001040074,0.00007557518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02889928,"threshold_uncertainty_score":0.9822375,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3211800240","doi":"10.2217/cer-2021-0221","title":"Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Fulvestrant; Nausea; Breast cancer; Quality of life (healthcare); Internal medicine; Oncology; Palbociclib; Cancer; Metastatic breast cancer; Estrogen receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.1333659944022162,"gpt":0.5031046785495277,"spread":0.3697386841473115,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001967975,0.0003113162,0.001871289,0.0007411913,0.0001220743,0.00003303721,0.0002684355,0.000140177,0.0002968155],"category_scores_gemma":[0.0003321359,0.0002690892,0.000232394,0.001823796,0.0004860354,0.0005822902,0.0001164652,0.001440188,0.00000477839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00100968,"about_ca_system_score_gemma":0.001532765,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001105905,"about_ca_topic_score_gemma":0.0002527684,"domain_scores_codex":[0.9931695,0.002823742,0.001192416,0.0004580545,0.001743422,0.0006128456],"domain_scores_gemma":[0.9923293,0.002220898,0.000838847,0.0004513021,0.003804968,0.0003547087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09122621,0.004560722,0.4772522,0.0006146815,0.00163302,0.001109784,0.008230328,0.005126881,0.2541439,0.0001572839,0.00003532426,0.1559097],"study_design_scores_gemma":[0.01213964,0.003049015,0.6077296,0.001636269,0.00007145193,0.0003458864,0.005867952,0.0002096992,0.3680626,0.0002916616,0.0003976791,0.0001986587],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928979,0.005048768,0.0002070207,0.0002580366,0.0004595929,0.0006855835,0.0000330168,0.00001493276,0.0003951514],"genre_scores_gemma":[0.9986938,0.0001688221,0.0008228176,0.00001443633,0.0001534713,0.00007309835,0.00001343586,0.0000416295,0.0000184507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.155711,"threshold_uncertainty_score":0.9999762,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2289680983","doi":"10.2217/cer.15.66","title":"Better research reporting to improve the utility of routine data for making better treatment decisions","year":2016,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Medicine; Checklist; Comparative effectiveness research; Observational study; Transparency (behavior); Electronic health record; Family medicine; Data collection; Alternative medicine; Medical emergency; Health care; Computer science; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.9333516952933743,"gpt":0.7129547362859485,"spread":0.2203969590074257,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2707336,0.0004350625,0.006150951,0.001860404,0.0007156605,0.0002154531,0.00239168,0.0003041283,0.000154168],"category_scores_gemma":[0.0610029,0.0002811077,0.0008192463,0.001024184,0.0004343671,0.0005309549,0.0008775965,0.001328338,0.000269528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002258771,"about_ca_system_score_gemma":0.002039473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001431436,"about_ca_topic_score_gemma":0.00004953343,"domain_scores_codex":[0.9692037,0.01427201,0.01332236,0.001210922,0.0008981848,0.001092814],"domain_scores_gemma":[0.8779338,0.1023546,0.01394102,0.002758059,0.002699839,0.0003127143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001271728,0.001362574,0.005159816,0.02604706,0.004868482,0.0000367701,0.003837012,0.00002790686,0.00001252745,0.008397533,0.06978233,0.8791962],"study_design_scores_gemma":[0.0009215522,0.001132405,0.00208081,0.01891719,0.00006899669,0.00003186382,0.0003882376,0.0003529994,0.00001741024,0.008967546,0.9668255,0.0002954555],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005518463,0.9537748,0.02138596,0.006094093,0.0009369875,0.009253262,0.002220918,0.000008116341,0.000807456],"genre_scores_gemma":[0.09724722,0.8836665,0.007949241,0.0003734406,0.006236012,0.003517773,0.000161757,0.0002740176,0.0005740651],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8970432,"threshold_uncertainty_score":0.9999641,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402428455","doi":"10.57264/cer-2024-0111","title":"A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Palbociclib; Quality of life (healthcare); Clinical trial; Metastatic breast cancer; Breast cancer; Internal medicine; Randomized controlled trial; Oncology; Cancer; Physical therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1381675298707819,"gpt":0.5181216320709223,"spread":0.3799541022001404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.007131086,0.0006622336,0.01561557,0.001270136,0.00005356151,0.00001445308,0.0004020326,0.0001646004,0.00003598484],"category_scores_gemma":[0.0005246291,0.0003279745,0.0006976433,0.003040402,0.0005002197,0.0002239145,0.00007898417,0.00183399,0.000004103617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001730908,"about_ca_system_score_gemma":0.00398402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001829068,"about_ca_topic_score_gemma":0.00002758869,"domain_scores_codex":[0.9829451,0.009520236,0.004203045,0.0004599988,0.002365752,0.0005059129],"domain_scores_gemma":[0.98669,0.003340035,0.004894536,0.0005849228,0.004222817,0.0002676518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.005264298,0.0009306332,0.01497425,0.9562668,0.006108862,0.00002551066,0.000270298,0.00002244575,0.000001490275,0.00002807143,0.00000573183,0.01610164],"study_design_scores_gemma":[0.005180357,0.002909251,0.0640571,0.9256127,0.001636846,0.00006768248,0.0001340568,0.000001289171,0.000005130011,0.00001501917,0.0001336304,0.0002469449],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02365832,0.9679128,0.00003393424,0.00008586799,0.00006004497,0.008013125,0.0002036917,0.00001079214,0.00002140627],"genre_scores_gemma":[0.06708774,0.9320188,0.00007168607,0.00001325314,0.00002048489,0.0006369369,0.00002672281,0.00009069682,0.00003372438],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.04908285,"threshold_uncertainty_score":0.9999172,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034390498","doi":"10.2217/cer.12.37","title":"Optimizing the design of pragmatic trials: key issues remain","year":2012,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Intervention (counseling); Context (archaeology); Task (project management); Risk analysis (engineering); Clinical trial; Clinical study design; Management science; Research design; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.9072114903384465,"gpt":0.670455447640037,"spread":0.2367560426984096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4304324,0.0004734405,0.01134661,0.001747129,0.000369475,0.00018425,0.001371749,0.0003694924,0.0002630244],"category_scores_gemma":[0.02857172,0.0003373094,0.001161079,0.001033036,0.0004430776,0.000675731,0.0001802005,0.001828827,0.000555936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001517051,"about_ca_system_score_gemma":0.001463704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008072639,"about_ca_topic_score_gemma":0.000004452715,"domain_scores_codex":[0.9055967,0.08025865,0.01226102,0.0004523545,0.0006875534,0.0007436771],"domain_scores_gemma":[0.8669191,0.1153079,0.01570708,0.0007608029,0.001049595,0.0002555362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001978452,0.003698179,0.0005643895,0.3610917,0.02157115,0.0000471751,0.06554909,0.01447475,0.00001433415,0.3562472,0.05418261,0.120581],"study_design_scores_gemma":[0.0009672976,0.0006884734,0.000102606,0.02520185,0.0003021488,0.00006858406,0.001504617,0.0005982604,0.000010949,0.01077282,0.959344,0.0004383484],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007203906,0.9636545,0.02982512,0.0007175035,0.0007405073,0.004304057,0.00008137277,0.000006810229,0.0005980837],"genre_scores_gemma":[0.001384489,0.991458,0.005130788,0.00003351225,0.00135701,0.0004079999,0.000009161043,0.00006934871,0.000149707],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9051614,"threshold_uncertainty_score":0.9999079,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4229044080","doi":"10.2217/cer-2021-0314","title":"Economic burden of drug overdose deaths before and during the COVID-19 pandemic in the USA","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Drug overdose; Quarter (Canadian coin); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Emergency medicine; Medical emergency; Environmental health; Poison control; Virology; Infectious disease (medical specialty); Disease; Outbreak; Geography; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07913024373929181,"gpt":0.4399704730732,"spread":0.3608402293339081,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005345707,0.0001242888,0.0004863679,0.0003641613,0.0003632365,0.00002672018,0.0003272783,0.00002394815,0.0001027282],"category_scores_gemma":[0.0001689203,0.00006854352,0.00011067,0.0003549413,0.0002812774,0.00009330481,0.0002064529,0.0009688978,0.000003344706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00120969,"about_ca_system_score_gemma":0.0007611739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009688176,"about_ca_topic_score_gemma":0.0003827933,"domain_scores_codex":[0.9950576,0.003432396,0.0003612948,0.0001668846,0.0007335901,0.0002481804],"domain_scores_gemma":[0.9962102,0.003103055,0.0001959691,0.0002386259,0.0001465663,0.0001056271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003084649,0.0003152471,0.9495882,0.000253343,0.0002273974,0.0001436452,0.03507507,0.008791722,0.001725956,0.0004584798,0.0001142485,0.0002220478],"study_design_scores_gemma":[0.004431698,0.001328976,0.9746066,0.00008626012,0.00004035239,0.0006416311,0.01582423,0.0003872186,0.0005935304,0.001012267,0.0009891563,0.00005805805],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961122,0.001534431,0.00001309028,0.00102928,0.00005734293,0.001027196,0.0000142838,0.000002355941,0.0002098567],"genre_scores_gemma":[0.9995266,0.0001518581,0.0000100976,0.00003197963,0.00007872339,0.000121852,0.000001893616,0.000009811007,0.00006714775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02501843,"threshold_uncertainty_score":0.4209433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3127294621","doi":"10.2217/cer-2020-0173","title":"Factors affecting treatment selection and overall survival for first-line EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Osimertinib; Lung cancer; Oncology; Internal medicine; Retrospective cohort study; Tyrosine-kinase inhibitor; Tyrosine kinase; Cohort; Cancer; Targeted therapy; Erlotinib; Epidermal growth factor receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.1177597828406142,"gpt":0.4684437114122273,"spread":0.3506839285716131,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007950289,0.0002160336,0.0007053835,0.0003464637,0.0002465526,0.00006510709,0.00004648868,0.00007786065,0.000026591],"category_scores_gemma":[0.00008900695,0.0001481157,0.0001556532,0.0004940743,0.00005059782,0.0001605033,0.00002358535,0.0003432773,3.703598e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001583033,"about_ca_system_score_gemma":0.0008158888,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003687914,"about_ca_topic_score_gemma":0.00092064,"domain_scores_codex":[0.998126,0.0005737306,0.0003234947,0.0002770672,0.0003680936,0.0003316033],"domain_scores_gemma":[0.9962236,0.002089983,0.0001534114,0.00009761385,0.001273326,0.0001620105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005896675,0.004171815,0.8517749,0.0008542677,0.001379971,0.0001487829,0.008075744,0.004777083,0.1164749,0.00005247746,0.0001064732,0.006286884],"study_design_scores_gemma":[0.01672782,0.005332877,0.5936159,0.0008177549,0.0001446909,0.00001897774,0.0009025212,0.001808168,0.3801557,0.00006546509,0.0002759815,0.0001341387],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910594,0.005233133,0.001456277,0.0002365695,0.0002584193,0.001628968,0.00001899251,0.000006184452,0.0001020518],"genre_scores_gemma":[0.9978713,0.001226765,0.0001795111,0.000007597515,0.0003265926,0.0001849627,0.00001622027,0.00002410105,0.0001629938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2636808,"threshold_uncertainty_score":0.6039982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4225010633","doi":"10.2217/cer-2021-0205","title":"Sex-based differences in the outcomes of patients with lung carcinoids","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Hazard ratio; Lung cancer; Epidemiology; Lung; Incidence (geometry); Population; Multivariate analysis; Carcinoid tumors; Gastroenterology; Oncology; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.08334786066464446,"gpt":0.4323258422620821,"spread":0.3489779815974377,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00304039,0.0001477547,0.0008111287,0.0008388372,0.0002050417,0.00002332409,0.0005276064,0.000006459742,0.00007590724],"category_scores_gemma":[0.0003780765,0.00007762103,0.0001180754,0.001225448,0.0004030326,0.0001354074,0.0001287236,0.001549552,8.349135e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002854005,"about_ca_system_score_gemma":0.00055319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004497467,"about_ca_topic_score_gemma":0.00001383245,"domain_scores_codex":[0.9903051,0.005510519,0.000402007,0.0001847294,0.003203196,0.0003944328],"domain_scores_gemma":[0.9927517,0.005602327,0.0002238935,0.0002617203,0.001055865,0.0001045155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005982873,0.001544658,0.9894735,0.0001677357,0.0001243872,0.0005947586,0.0006046757,0.0006293783,0.0005793391,0.00008754609,0.00008789886,0.0001232201],"study_design_scores_gemma":[0.004945107,0.007854161,0.9791002,0.00009166039,0.00002117827,0.00005545076,0.001780028,0.0002351212,0.005625559,0.0001200579,0.0001046947,0.00006683789],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976508,0.0002446914,0.00007460108,0.0003895988,0.00004739657,0.001268844,0.00001490314,0.000002984114,0.0003061655],"genre_scores_gemma":[0.9996924,0.000004478602,0.00005671831,0.00002403433,0.00002133951,0.0001470429,0.000003316057,0.0000119766,0.00003873308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01037339,"threshold_uncertainty_score":0.6732119,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308668157","doi":"10.2217/cer-2022-0160","title":"Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review","year":2022,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Anticholinergic; Medicine; Overactive bladder; Intensive care medicine; Health care; Anticholinergic agents; Systematic review; Indirect costs; MEDLINE; Internal medicine; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1571108010577504,"gpt":0.4854165608149944,"spread":0.328305759757244,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007672658,0.0005078292,0.006620742,0.002106755,0.0001270147,0.0000883698,0.0003829061,0.0001976811,0.000069758],"category_scores_gemma":[0.0006054274,0.000317665,0.0004759597,0.001776617,0.0002981526,0.0004601368,0.0002512859,0.004266294,0.000004709581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001077959,"about_ca_system_score_gemma":0.002916721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001418569,"about_ca_topic_score_gemma":0.00002454114,"domain_scores_codex":[0.9832914,0.01246999,0.001657836,0.0005296798,0.001507088,0.0005439887],"domain_scores_gemma":[0.9864134,0.01009863,0.001201941,0.000514108,0.001424487,0.0003474843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.004112503,0.0003220941,0.0001839797,0.9814718,0.001385106,0.002047742,0.001597952,0.00001758051,0.000001618926,0.00007065888,0.0001114331,0.008677579],"study_design_scores_gemma":[0.002373361,0.007117189,0.0003684277,0.9554823,0.0006731117,0.005145237,0.0005485332,0.00004761455,0.000005835971,0.0000210756,0.02796172,0.0002556182],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004821687,0.9875322,0.000003253882,0.00008160394,0.00006067061,0.007244749,0.0001081994,0.000004113311,0.0001435387],"genre_scores_gemma":[0.01173372,0.9874513,0.00004408518,0.000006916046,0.0001287807,0.0004438382,0.00006998459,0.00005710423,0.00006428301],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02785029,"threshold_uncertainty_score":0.9999275,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889227700","doi":"10.2217/cer-2018-0020","title":"Relative effectiveness of sunitinib versus everolimus in advanced pancreatic neuroendocrine tumors: an updated matching-adjusted indirect comparison","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Sunitinib; Everolimus; Medicine; Hazard ratio; Internal medicine; Oncology; Neuroendocrine tumors; Urology; Confidence interval; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1270138429126655,"gpt":0.4709140956346132,"spread":0.3439002527219477,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005218398,0.0005249315,0.002826407,0.002540981,0.0002385551,0.0000610116,0.0007323481,0.00004169154,0.0001190204],"category_scores_gemma":[0.002351536,0.0004394542,0.0002714995,0.003511372,0.001423987,0.001336384,0.0002873915,0.002803272,0.00003388675],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007882917,"about_ca_system_score_gemma":0.0009314966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002092718,"about_ca_topic_score_gemma":0.0001721169,"domain_scores_codex":[0.9793429,0.01496242,0.001435485,0.0006962858,0.002377169,0.001185731],"domain_scores_gemma":[0.9823334,0.01109936,0.0008040787,0.0006685102,0.004499515,0.0005951827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.3733006,0.00642149,0.1777975,0.002230524,0.001372653,0.01001671,0.00300981,0.003214957,0.4188482,0.001391499,0.0001041078,0.002291936],"study_design_scores_gemma":[0.01802994,0.03158589,0.5350451,0.002586586,0.00009545232,0.00100916,0.001487073,0.0006698312,0.4073871,0.001710786,0.0001135412,0.000279546],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945049,0.0004429781,0.0002750783,0.00006577899,0.0003402761,0.002510725,0.00001959698,0.00004049985,0.001800171],"genre_scores_gemma":[0.9989374,0.00004941639,0.0005514594,0.000007028356,0.0001926902,0.0001047633,0.00003378766,0.00007769946,0.00004570384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3572475,"threshold_uncertainty_score":0.9998057,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401428163","doi":"10.57264/cer-2023-0171","title":"Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Grifols; Argenx; Sanofi; Alnylam Pharmaceuticals; UCB Pharma; Alexion Pharmaceuticals; Pfizer; Amgen","keywords":"Medicine; Meta-analysis; Drug; Intensive care medicine; Intravenous drug; Immune system; MEDLINE; Internal medicine; Pharmacology; Immunology; Human immunodeficiency virus (HIV)","retraction":null,"screen_n_in":null,"score":{"opus":0.3327499208702503,"gpt":0.5498842533511791,"spread":0.2171343324809288,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002793387,0.0003989456,0.009303096,0.0006450862,0.00007241348,0.00005242905,0.0001455999,0.00007835052,0.00003374961],"category_scores_gemma":[0.0005265088,0.0001723271,0.00116075,0.00141245,0.0001652265,0.0001354888,0.00005897157,0.0007487844,0.00000111546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000208553,"about_ca_system_score_gemma":0.0005593011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005098354,"about_ca_topic_score_gemma":0.0001785799,"domain_scores_codex":[0.9932465,0.003501014,0.001821465,0.0003477911,0.0008150034,0.0002682531],"domain_scores_gemma":[0.9912312,0.005858863,0.00160757,0.0002178881,0.0009529401,0.0001315652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.005849239,0.0007788089,0.0000182529,0.7620169,0.2264565,0.0003266362,0.0006320953,0.000001614008,3.058104e-7,0.000004772681,0.000008757198,0.003906144],"study_design_scores_gemma":[0.0009365169,0.01016788,0.00006621725,0.2213236,0.7650824,0.0007791498,0.0005345758,0.00002020545,0.000008101404,0.00003961901,0.0008749458,0.0001668287],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003027845,0.9882559,0.00002876945,0.00007915877,0.00002495008,0.008466368,0.00007503056,0.000003189846,0.00003878932],"genre_scores_gemma":[0.200084,0.7986924,0.00004346974,0.000003053431,0.00001137458,0.001088915,0.00002540971,0.00001517227,0.0000361877],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5406933,"threshold_uncertainty_score":0.7027297,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4292583104","doi":"10.2217/cer-2022-0074","title":"Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Transthyretin; Amyloidosis; Comorbidity; Demographics; Pediatrics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1612373195103961,"gpt":0.4917790906481361,"spread":0.33054177113774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003176396,0.0001555543,0.0005175835,0.0002877227,0.0003402121,0.00002071949,0.0002711846,0.00008536378,0.00004880186],"category_scores_gemma":[0.000325335,0.0001388218,0.0002153694,0.0004149577,0.0003416195,0.00001722248,0.0001780281,0.0004820091,0.000001226979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001153876,"about_ca_system_score_gemma":0.0003102827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004709248,"about_ca_topic_score_gemma":0.00006652684,"domain_scores_codex":[0.9939511,0.004220076,0.0006343691,0.0002887114,0.0006487641,0.000256999],"domain_scores_gemma":[0.9971102,0.001284234,0.0003699826,0.0002109447,0.0008709285,0.0001537418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001129571,0.0009231315,0.9821343,0.0001363564,0.0003862419,0.00002484051,0.0008378415,0.0004023922,0.005636255,0.000543339,0.0006757673,0.007169946],"study_design_scores_gemma":[0.002063661,0.007407838,0.9355983,0.0001040165,0.00006140414,0.0000681349,0.001939881,0.00006147767,0.04915364,0.0004409222,0.00296958,0.0001311463],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942707,0.003622382,0.0006205823,0.0005884971,0.0001529047,0.0005870807,0.00008119321,0.000003199262,0.00007341218],"genre_scores_gemma":[0.9975677,0.001708562,0.0002597082,0.00003299314,0.00009502681,0.0002552093,0.00003721072,0.00001914274,0.00002442599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04653601,"threshold_uncertainty_score":0.5660988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}